New York State Common Retirement Fund Atara Biotherapeutics, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.44 - $1.22 $61 - $170	140 Added 0.35%	39,681 $28,000
Q4 2023 Feb 01, 2024	SELL	$0.23 - $1.74 $32 - $248	-143 Reduced 0.36%	39,541 $20,000
Q3 2023 Nov 07, 2023	BUY	$1.41 - $2.31 $442 - $725	314 Added 0.8%	39,684 $59,000
Q2 2023 Aug 07, 2023	SELL	$1.5 - $3.04 $328 - $665	-219 Reduced 0.55%	39,370 $63,000
Q1 2023 May 02, 2023	SELL	$2.8 - $5.46 $54,642 - $106,551	-19,515 Reduced 33.02%	39,589 $115,000
Q4 2022 Jan 30, 2023	SELL	$2.85 - $5.18 $202 - $367	-71 Reduced 0.12%	59,104 $194,000
Q3 2022 Nov 08, 2022	BUY	$2.85 - $8.73 $726 - $2,226	255 Added 0.43%	59,175 $224,000
Q2 2022 Aug 04, 2022	SELL	$4.69 - $9.84 $25,912 - $54,366	-5,525 Reduced 8.57%	58,920 $459,000
Q1 2022 May 05, 2022	BUY	$8.44 - $16.89 $56,244 - $112,554	6,664 Added 11.53%	64,445 $599,000
Q4 2021 Feb 02, 2022	SELL	$14.7 - $19.89 $2,837 - $3,838	-193 Reduced 0.33%	57,781 $911,000
Q3 2021 Nov 02, 2021	SELL	$11.99 - $17.9 $155,786 - $232,574	-12,993 Reduced 18.31%	57,974 $1.04 Million
Q2 2021 Aug 02, 2021	BUY	$12.89 - $16.58 $8,597 - $11,058	667 Added 0.95%	70,967 $1.1 Million
Q4 2020 Feb 08, 2021	BUY	$12.67 - $26.23 $224,259 - $464,271	17,700 Added 33.65%	70,300 $1.38 Million
Q2 2020 Aug 07, 2020	BUY	$7.53 - $14.93 $28,614 - $56,734	3,800 Added 7.79%	52,600 $766,000
Q3 2019 Nov 07, 2019	BUY	$12.03 - $19.94 $60,150 - $99,700	5,000 Added 11.42%	48,800 $689,000
Q1 2019 May 08, 2019	BUY	$28.4 - $41.74 $73,840 - $108,524	2,600 Added 6.31%	43,800 $1.74 Million
Q4 2018 Feb 08, 2019	SELL	$30.9 - $42.97 $203,940 - $283,602	-6,600 Reduced 13.81%	41,200 $1.43 Million
Q3 2018 Nov 07, 2018	BUY	$35.05 - $43.5 $91,129 - $113,100	2,600 Added 5.75%	47,800 $1.98 Million
Q2 2018 Aug 10, 2018	BUY	$35.15 - $51.45 $333,925 - $488,775	9,500 Added 26.61%	45,200 $1.66 Million
Q1 2018 May 10, 2018	BUY	$18.0 - $48.35 $102,600 - $275,595	5,700 Added 19.0%	35,700 $1.39 Million
Q4 2017 Feb 13, 2018	BUY	$13.2 - $18.1 $69,960 - $95,930	5,300 Added 21.46%	30,000 $543,000
Q2 2017 Aug 11, 2017	BUY	N/A	24,700	24,700 $346,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account